APA (7th ed.) Citation

Y, H., S, K., T, P., H, H., S, P., J, K., . . . M, L. (2024). Reduction of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant infection by blocking the epidermal growth factor receptor (EGFR) pathway. Microbiology spectrum, 12(11), e0158324. https://doi.org/10.1128/spectrum.01583-24

Chicago Style (17th ed.) Citation

Y, Han, Kim S, Park T, Hwang H, Park S, Kim J, Pyun J-c, and Lee M. "Reduction of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant Infection by Blocking the Epidermal Growth Factor Receptor (EGFR) Pathway." Microbiology Spectrum 12, no. 11 (2024): e0158324. https://doi.org/10.1128/spectrum.01583-24.

MLA (9th ed.) Citation

Y, Han, et al. "Reduction of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant Infection by Blocking the Epidermal Growth Factor Receptor (EGFR) Pathway." Microbiology Spectrum, vol. 12, no. 11, 2024, p. e0158324, https://doi.org/10.1128/spectrum.01583-24.